Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 101: 752-762, 2006. First published June 8, 2006; doi:10.1152/japplphysiol.00235.2006
8750-7587/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
101/3/752    most recent
00235.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Witczak, C. A.
Right arrow Articles by Sturek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Witczak, C. A.
Right arrow Articles by Sturek, M.

Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine

Carol A. Witczak,1 Brian R. Wamhoff,1,3 and Michael Sturek1,2,4

Departments of 1Medical Pharmacology and Physiology and 2Internal Medicine, and the Center for Diabetes & Cardiovascular Health, University of Missouri, Columbia, Missouri; 3Department of Molecular Physiology and Biological Physics, and the Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia; and 4Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana

Submitted 22 February 2006 ; accepted in final form 17 May 2006


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Aerobic exercise training is known to have profound cardioprotective effects in disease, yet cellular mechanisms remain largely undefined. We tested the hypothesis that increased sarcoplasmic reticulum Ca2+ buffering and increased voltage-gated Ca2+ channel density underlie coronary smooth muscle intracellular Ca2+ (Ca2+i) dysregulation in diabetic dyslipidemia and that exercise training would prevent these increases. Yucatan swine were maintained in 1) control, 2) alloxan-induced hyperglycemic, 3) high fat/cholesterol fed, 4) hyperglycemic plus high fat/cholesterol fed (diabetic dyslipidemic), and 5) diabetic dyslipidemic plus exercise-trained (treadmill running) conditions. After 20 wk, the heart was removed and smooth muscle cells isolated from the right coronary artery. We utilized fura-2 imaging of Ca2+i levels to separate the functional role of the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) from the Na+-Ca2+ exchanger and the plasmalemmal Ca2+-ATPase, and whole-cell patch clamp to examine voltage-gated Ca2+ channel current density (i.e., Ca2+ influx). Results indicated that diabetic dyslipidemia impaired plasmalemmal Ca2+ efflux, increased basal Ca2+i levels, increased SERCA protein and sarcoplasmic reticulum Ca2+i buffering, and elicited an ~50% decrease in voltage-gated Ca2+ channel current density. Exercise training concurrent with the diabetic dyslipidemic state restored plasmalemmal Ca2+ efflux, SERCA protein, sarcoplasmic reticulum Ca2+i buffering, and voltage-gated Ca2+ channel current density to control levels. Interestingly, basal Ca2+i levels were significantly lower in the exercise-trained group compared with control. Collectively, these results demonstrate a crucial role for exercise in the prevention of diabetic dyslipidemia-induced Ca2+i dysregulation.

hypercholesterolemia; sarcoendoplasmic reticulum Ca2+-ATPase; voltage-gated Ca2+ channel; Na+-Ca2+ exchange; intracellular Ca2+ buffering; Ca2+ extrusion


AEROBIC EXERCISE TRAINING elicits physiological adaptations that result in an improved quality of life in disease. For example, aerobic exercise is widely accepted to play a role in the prevention of both Type 2 diabetes (20) and coronary artery disease (4). Thus an understanding of the mechanisms by which exercise exerts a beneficial effect on these disease states could greatly enhance efforts to treat these conditions with pharmacological agents.

The combined conditions of hyperglycemia (diabetes) and dyslipidemia have been shown to accelerate the development and progression of vascular disease in both humans (11, 18, 25, 35) and swine (1, 2831). In swine, this leads to increased coronary artery constriction in response to the proinflammatory molecule prostaglandin F2{alpha} in vivo and in vitro (30) and increased constriction in response to endothelin-1 in vitro (30). Previous studies have suggested that the diabetic dyslipidemia-induced impairment in vascular reactivity is largely due to alterations in coronary smooth muscle intracellular Ca2+ (Ca2+i) regulation. These studies have shown that diabetic dyslipidemia significantly impairs Ca2+ efflux from the cell (45), increases basal Ca2+i levels (45), and increases sarcoplasmic reticulum Ca2+i buffering (23). Since it is currently thought that the increase in sarcoplasmic reticulum Ca2+i buffering is a compensatory alteration due to the impairment in Ca2+ efflux and the rise in Ca2+i levels, collectively these results suggest that pro-atherogenic factors present in the diabetic dyslipidemic state negatively impact the functional capacity of plasma membrane Ca2+ transporters. However, missing from this model is the impact of diabetic dyslipidemia on plasma membrane Ca2+ transporters involved in regulating Ca2+ influx, such as the L-type voltage-gated Ca2+ channels. Bowles et al. (6) have shown that hyperlipidemia alone decreased L-type voltage-gated Ca2+ channel density; however, the independent effect of hyperglycemia and synergistic effects of hyperglycemia and dyslipidemia have not been studied. Thus one aim of this study is to examine the effects of diabetes, hyperlipidemia, and diabetic dyslipidemia on coronary smooth muscle L-type voltage-gated Ca2+ channel current density.

Exercise training in healthy/normal animals has direct effects on the coronary vasculature, including enhanced vasodilatory responses to adenosine both in vivo and in vitro (15, 26, 27, 33), and reduced vasoconstrictor responses to norepinephrine and endothelin in vitro (9, 33). Along with these adaptations in coronary vasoreactivity, exercise training has been shown to increase Ca2+i buffering via mechanisms other than the sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) or the Na+-Ca2+ exchanger (NCX) (19), and to increase Ca2+ influx via L-type voltage-gated Ca2+ channels (8). Collectively, these results suggest enhanced coronary smooth muscle Ca2+i regulation with exercise training.

When exercise training is performed concurrent with the diabetic dyslipidemic state, it has been shown to attenuate vascular dysregulation, including an attenuation of the diabetic dyslipidemia-induced decrease in vasoconstriction in response to endothelin-1 in vitro (30). Consistent with this training-induced attenuation of vascular dysfunction, exercise training prevents the diabetic dyslipidemia-induced decrease in plasmalemmal Ca2+ efflux (45). Collectively, these results suggest that exercise training would prevent and/or attenuate diabetic dyslipidemia-induced alterations in SERCA, as well as plasma membrane Ca2+ transporters, such as the L-type voltage-gated Ca2+ channels. Thus we tested the hypothesis that increased Ca2+ buffering by the SERCA and increased voltage-gated Ca2+ channel density underlie coronary smooth muscle Ca2+i dysregulation in diabetic dyslipidemia and that exercise training would prevent these increases.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This study combined established protocols for examining diabetic dyslipidemia-induced coronary artery disease and endurance exercise training in a porcine model (810, 16, 37, 38). All procedures involving animals were approved by the Animal Care and Use Committee of the University of Missouri and complied fully with guidelines in the Guide for the Care and Use of Laboratory Animals (32) and the American Veterinary Medical Association Panel on Euthanasia (3).

Experimental Design

Male Yucatan swine (aged 8–12 mo, 35–45 kg) were obtained from the Sinclair Research Center (Columbia, MO) and then randomly assigned to one of five treatment groups for 20 wk as follows: 1) low-fat fed, sedentary [control (C), N = 6]; 2) alloxan-induced diabetes [diabetic (D), N = 8]; 3) high-fat, high-cholesterol fed [high fat (H), N = 8]; 4) alloxan-induced diabetes and high-fat, high-cholesterol fed [diabetic dyslipidemic (DD), N = 8]; and 5) alloxan-induced diabetes, high-fat, high-cholesterol fed plus aerobic exercise training [diabetic dyslipidemic plus exercise (DDX), N = 8].

As previously described (16), control and diabetic animals were fed a low-fat diet consisting of Purina mini-pig chow (Purina Mills, St. Louis, MO). All other animals were fed the high-fat, high-cholesterol diet consisting of Purina mini-pig chow supplemented with 2.0% cholesterol, 17% coconut oil, 2% corn oil, and 1% sodium cholate (16). The high-fat, high-cholesterol diet increased the %kcal of the diet from fat from 8 to 46%. All animals were fed once daily and given free access to water.

Hyperglycemia was induced by the intravenous administration of 100 mg/kg of the pancreatic beta-cell toxin alloxan monohydrate (Sigma-Aldrich, St. Louis, MO), as previously described (5, 16). Animals were monitored closely for 24 h after alloxan monohydrate administration to prevent the life-threatening drop in blood glucose levels triggered by the massive insulin release associated with alloxan-induced beta-cell death (34, 36). Fasting blood glucose levels and blood urea nitrogen levels were measured once a week using an Accu-Check blood glucose monitor (Boehringer Mannheim, Ridgefield, CT) and Azostix diagnostic strips (Bayer, Elkhart, IN), respectively. Pigs were maintained with fasting blood glucose levels between 300 and 400 mg/dl for the duration of the study using daily insulin injections as required.

Arterial blood samples were obtained from fasted swine at the time of death. Plasma was assayed for total cholesterol, high-density lipoprotein and low-density lipoprotein cholesterol, and total triglyceride levels as previously described (16, 44).

Exercise Training Procedures

To prevent any detrimental cardiac event in diabetic dyslipidemic swine with cardiovascular disease, the endurance exercise training protocol was modified from our early studies (810, 37, 38) and performed as previously described (45). This protocol complied fully with guidelines in the APS Resource Book for the Design of Animal Exercise Protocols (14). Briefly, exercise training consisted of treadmill running performed 4 days/wk for 16–18 wk with the last week corresponding to 20 wk of diabetic dyslipidemia. The daily 45-min training bout consisted of four stages: 1) a 5-min warm-up at 2.2 km/h, 2) 5 min at 3.8 km/h (~40–50% maximum heart rate), 3) 30 min at 4.8 km/h with a variable grade (~65–75% of maximum heart rate), and 4) a 5-min cool-down at 2.2 km/h. Heart rates were taken using a stethoscope just before the exercise bout and at the middle and end of stage 3. Throughout the 20-wk training period, training intensity was maintained in the desired heart rate range by altering the treadmill grade. Efficacy of training was assessed by measurements of resting heart rate and the treadmill grade (i.e., submaximal workload) at which 65–75% of maximal heart rate was achieved.

Tissue Removal and Isolation of Coronary Smooth Muscle Cells

The procedure for the isolation of the right coronary artery and the enzymatic dispersal of porcine coronary smooth muscle cells has been previously described (2123, 37). Briefly, at least 48 h after the completion of the 20-wk training period, swine were anesthetized with isoflurane gas (4%) and the heart surgically removed and rapidly placed in ice-cold physiological salt solution (PSS). The right coronary artery was dissected away from the myocardium, and distal arterial sections (4- to 5-mm lumen diameter) were incubated with a low-Ca2+ solution containing 294 U/ml collagenase, 5 U/ml elastase, 2 mg/ml bovine serum albumin, 1 mg/ml soybean trypsin inhibitor, and 0.4 mg/ml DNAse. Cells were enzymatically dispersed by incubation in a shaking water bath at 37°C for 60 min. The first fraction, consisting largely of endothelial cells, was removed and discarded. Additional collagenase solution was added, and the artery was incubated in the water bath for an additional 30 min. Smooth muscle cells from this fraction were removed from the collagenase solution and identified morphologically (41). All experiments were performed on freshly dispersed cells within 24 h of death and within 6 h of isolation from the artery.

Measurement of Ca2+i Levels

Measurements of whole cell Ca2+i levels were obtained at room temperature (22–23°C) using the fluorescent Ca2+ indicator, fura 2, and the InCa++ Calcium Imaging System (Intracellular Imaging, Cincinnati, OH) as previously described by our laboratory (21–23, 37, 38). Briefly, freshly dispersed cells were incubated with 2.5 µM fura 2-AM (Molecular Probes, Eugene, OR) in a shaking water bath at 37°C for 20 min and washed in a low-Ca2+-containing solution supplemented with Eagle's minimal essential storage media for 20 min. An aliquot of fura 2-loaded cells was placed on a coverslip contained within a constant-flow superfusion chamber that was mounted on an inverted epifluorescent microscope (Nikon, model TMS-F). Fura 2 was excited by light from a 300-W xenon arc lamp that was passed through a computer-controlled filter changer containing 340 ± 10 and 380 ± 10 nm band-pass filters. The fluorescence emission was collected at 510 nm using a monochrome charge-coupled device camera (COHU, San Diego, CA) attached to a 100-MHz Pentium data acquisition computer. Whole cell fura 2 fluorescence was expressed as the ratio of the 340:380-nm ratio of the fura 2 emission.

Solutions.   The PSS contained (in mM) 138 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, and was titrated to a pH of 7.4 with NaOH. The 19 mM Na+ solution contained (in mM) 15 NaCl, 124 LiCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, and was titrated to a pH of 7.4 with NaOH. The 80 mM K+ solution contained (in mM) 65 NaCl, 80 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, and was titrated to a pH of 7.4 with NaOH. The Ca2+-free solution (~100 nM Ca2+) contained (in mM) 138 NaCl, 1 MgCl2, 5 KCl, 10 HEPES, 0.01 K+-EGTA, 10 glucose, titrated to a pH of 7.4 with NaOH. The caffeine solutions consisted of either the PSS or the Ca2+-free solution supplemented with 5 mM caffeine.

Protocol to assess total plasmalemmal Ca2+ efflux.   Experimental protocols were designed to assess total Ca2+ efflux via both the NCX and the plasma membrane Ca2+-ATPase (PMCA). Cells were superfused with PSS for 2 min followed by exposure to an 80 mM K+ (depolarizing) solution for 10 min. The depolarizing step was performed to allow for Ca2+ influx via voltage-gated Ca2+ channels and the maximal loading of the sarcoplasmic reticulum Ca2+ store. Cells were allowed to recover in PSS for 3 min before superfusion with a Ca2+-free solution and depletion of the sarcoplasmic reticulum Ca2+ store with 5 mM caffeine. The nearly complete absence of Ca2+ in the extracellular solution eliminated possible Ca2+ influx, whereas caffeine prevented the accumulation of Ca2+ into the sarcoplasmic reticulum via SERCA by causing persistent opening of ryanodine receptors (40). (Graphs demonstrating the experimental protocol, the mean ± SE for key levels and times for the caffeine response, and the caffeine response time to half recovery are shown together in RESULTS for clarity.)

Protocol to assess Ca2+ efflux via the NCX and the PMCA.   To separately assess Ca2+ efflux via the NCX and/or the PMCA, forward mode activity of the NCX was inhibited by superfusion with a low (19 mM) Na+ solution in the presence or absence of the irreversible SERCA inhibitor, thapsigargin (10 µM). Cells were superfused with PSS for 2 min followed by exposure to an 80 mM K+ (depolarizing) solution for 4 min. Cells were allowed to recover in PSS for 2 min before superfusion with a 5 mM caffeine solution in the absence or presence of thapsigargin. The caffeine emptied the sarcoplasmic reticulum Ca2+ store, whereas the thapsigargin prevented reaccumulation of the Ca2+ by SERCA. Cells were allowed to recover in PSS for 2 min and then superfused with a low (19 mM) Na+ solution to inhibit Ca2+ efflux via NCX activity. The low Na+ solution in the absence of thapsigargin mainly assessed whether the NCX was essential for maintenance of Ca2+i after caffeine-induced depletion of the sarcoplasmic reticulum Ca2+i store, whereas the low Na+ solution in the presence of thapsigargin mainly assessed the role of the PMCA. Thus the change in the fura 2 signal in response to the 19 mM Na+ with thapsigargin solution primarily represents the balance between Ca2+ influx and Ca2+ extrusion via the PMCA. (Graphs demonstrating the experimental protocol, the mean ± SE for key levels and times for the 19 mM Na+ responses, and the change in the fura 2 ratio in response to the 19 mM Na+ solutions are shown together in RESULTS for clarity.)

Protocol to assess sarcoplasmic reticulum Ca2+ buffering.   To assess sarcoplasmic reticulum Ca2+ buffering capacity, we utilized a protocol that has previously been shown in our laboratory to primarily assess sarcoplasmic reticulum Ca2+ uptake when Ca2+ influx is known (23). Briefly, cells were superfused with PSS for 2 min followed by exposure to an 80 mM K+ (depolarizing) solution for 10 min. The depolarizing step was performed to allow for Ca2+ influx via voltage-gated Ca2+ channels and the maximal loading of the sarcoplasmic reticulum Ca2+ store. Cells were allowed to recover in PSS for 3 min before superfusion with a nominally Ca2+-free solution and depletion of the sarcoplasmic reticulum Ca2+ store with 5 mM caffeine. Cells were then superfused with a second 80 mM K+ solution for 10 min to allow for Ca2+ influx and the time to reach the half-maximal response measured. The time to reach the half-maximal Ca2+i level in response to the second 80 mM K+ exposure is largely indicative of SERCA activity, since the juxtaposition of the sarcoplasmic reticulum creates a buffer barrier (i.e., the superficial buffer barrier), whereby a large fraction of the Ca2+ entering the cell through voltage-gated Ca2+ channels is sequestered into the sarcoplasmic reticulum Ca2+ store (12, 13, 24). The quantification of Ca2+ influx through voltage-gated Ca2+ channels with direct patch-clamp measures (see below) provides more confidence regarding the contribution of sarcoplasmic reticulum Ca2+ buffering to the time to reach the half-maximal Ca2+i response. (Graphs demonstrating the experimental protocol, the mean ± SE for key levels and times for the 80 mM K+ responses, and the time to reach a half-maximal response for the 80 mM K+ solutions are shown together in RESULTS for clarity.)

Immunoblot Analysis of SERCA2b Protein Expression

Immunoblots for the Ca2+ transporter, SERCA2b, were performed according to methods designed in our laboratory for porcine coronary arteries (23). Briefly, frozen proximal segments of the circumflex artery were homogenized on ice in a hypotonic homogenization buffer containing (in mM) 1 NaHCO3, 5 CaCl2, and 10 Tris supplemented with the protease inhibitors (in mM) 1 phenylmethylsulfonyl fluoride, 0.002 leupeptin, 0.002 aprotinin, and 0.002 pefablocSC. The homogenate was centrifuged at 14,000 g for 15 min, the supernatant removed, and the pellet resuspended in Laemmli buffer (Bio-Rad Laboratories, Hercules, CA). The homogenate was centrifuged at 14,000 g for 15 min, and the supernatant (membrane fraction) was removed. Total membrane protein content was assessed using the Bicinchoninic acid method (Pierce, Rockford, IL) and the absorbance measured at 562 nm. A 20-µg sample of total membrane protein was loaded onto a 4–20% Bio-Rad ready gel (Bio-Rad Laboratories) and run at 110 V for ~60 min. Proteins were transferred onto a polyvinylidene difluoride Hybond-P membrane at 75 V for 75 min. The membrane was blocked with 5% nonfat dry milk, x1 Tris-buffered saline, and 0.01% Tween solution for 60 min to prevent nonspecific antibody binding. The anti-SERCA2b Ca2+-ATPase (1:1,000) primary antibody (Affinity Bioreagents, Golden, CO) was added into the blocking solution and allowed to bind to the proteins at room temperature overnight. A horseradish peroxide-conjugated mouse secondary antibody (1:5,000) was incubated with the membrane for 60 min at room temperature. The secondary antibody was detected using electrochemiluminescence detection reagents (Amersham Biosciences, Piscataway, NJ). Densitometric analysis of immunoblots was performed using Scion software (Frederick, MD). The protein expression of SERCA2b was assessed as the ratio of the density of the treatment group to the control group.

Whole Cell Voltage Clamp Analysis to Assess Functional L-Type Voltage-Gated Ca2+ Channel Expression

Whole cell currents were measured at room temperature (22–23°C) using a standard whole cell voltage clamp technique as used routinely by our laboratory (2, 7, 8, 10, 19, 38, 39). Cells were initially superfused with PSS during gigaseal formation with 2–5 M{Omega} heat-polished glass pipette containing pipette solution containing (in mM) 120 CsCl, 10 tetraethylammonium chloride, 1 MgCl2, 20 HEPES, 5 Na2ATP, 0.5 Tris GTP, 10 EGTA, and then titrated to a pH of 7.2. After whole cell configuration, the superfusate was switched to PSS with tetraethylammonium chloride substituted for NaCl and either 2 mM Ca2+ or 10 mM Ba2+ as the charge carrier. Whole cell currents were amplified with a List EPC-7 patch clamp with a 0.5–50 G{Omega} capacitance feedback resistance headstage and filtered through an eight-pole low-pass filter with a cutoff frequency of 400 Hz. Capacity currents were filtered at low-pass cutoff frequency of 8.4 kHz. Leak subtraction was not performed. Calcium channel currents were expressed as pA/pF of membrane capacitance to normalize for plasmalemmal area. Data acquisition and analyses were performed with a Labmaster analog-to-digital converter and AxoBASIC 1.0 data acquisition software (Axon Instruments, Sunnyvale, CA). Cells were constantly superfused at ~1–2 ml/min.

Statistical Analysis

Statistical significance was defined as P < 0.05, and the statistical analyses used to test significance for each measurement are described below. All data are presented as the mean of the group ± SE. For the body weight, blood measurements, and resting heart rate measurements presented in Table 1, statistical significance was assessed by one-way analysis of variance and Fisher's least significant difference analysis. For the treadmill incline to maintain 65–75% maximal heart rate measurements, statistical significance between the diabetic dyslipidemic and exercise-trained diabetic dyslipidemic groups was assessed by t-tests. The number of animals in each group is indicated in the body of the table below the treatment group. For the Ca2+i measurements and whole cell patch clamp analysis, statistical significance between treatment groups was determined by one-way analysis of variance and Student-Newman-Keuls post hoc analysis. The numbers of animals and cells for groups in each experiment are indicated in the body of the figure captions as N = pigs/cells. The number of cells was utilized as the N value for statistical analysis. For the immunoblot analysis, statistical significance between treatment groups was determined by one-way analysis of variance and Student-Newman-Keuls post hoc analysis. The number of animals utilized in each group is indicated in the body of the figure captions as N = pigs.


View this table:
[in this window]
[in a new window]
 
Table 1. In vivo indicators of diabetes, hyperlipidemia, diabetic dyslipidemia, and exercise training

 

    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
In Vivo Indicators of Diabetic Dyslipidemia and Exercise Training

Table 1 contains a summary of the in vivo data obtained in this study (30). The change in body weight over the 20-wk study was significantly lower in the diabetic group compared with all other groups, and the exercise-trained swine had a greater increase in body weight percentage compared with the sedentary, diabetic dyslipidemic swine. Fasting blood glucose levels in the diabetic, diabetic dyslipidemic, and exercise-trained diabetic dyslipidemic swine were maintained at levels approximately sixfold higher than control. The average daily insulin dose was not different between these groups. Blood urea nitrogen levels were not significantly elevated in any of the hyperglyemic groups, demonstrating that the pancreatic beta-cell toxin alloxan did not elicit renal toxicity.

Fasting total cholesterol levels were elevated approximately fivefold in all groups fed the high-fat, high-cholesterol diet. The ratio of low-density lipoprotein to high-density lipoprotein (LDL:HDL) cholesterol was significantly higher in both diabetic dyslipidemic groups compared with control. Total fasting plasma triglyceride levels were elevated ~3.5-fold with diabetic dyslipidemia, and exercise training prevented this rise.

Efficacy of the exercise training protocol was verified by two measures: 1) resting heart rate and 2) treadmill grade to elicit 65–75% of maximal heart rate. Similar to previous studies from our group, after 20 wk of training, the exercise-trained diabetic dyslipidemic swine had significantly lower resting heart rates compared with the sedentary, diabetic dyslipidemic swine (5, 30, 43). The exercise-trained swine were also able to tolerate running at an increased workload, as evidenced by a significant increase in the treadmill grade at which they achieved 65–75% of their maximal heart rate.

Exercise Training Prevented the Diabetic Dyslipidemia-Induced Rise in Basal Ca2+i Levels

Basal Ca2+i levels were assessed by the 340:380-nm ratio of the fura 2 emission (fura 2 ratio) in PSS before any experimental perturbation. As shown in Fig. 1, basal Ca2+i levels were significantly increased in cells from diabetic dyslipidemic swine over the control, diabetic, and hyperlipidemic swine.Exercise training concurrent with the diabetic dyslipidemic state significantly lowered the basal Ca2+i levels below all groups.


Figure 1
View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1. Exercise training significantly decreased the diabetic dyslipidemia-induced rise in basal intracellular Ca2+ (Ca2+i) levels. Basal Ca2+i levels were significantly increased (*P < 0.05) in cells from diabetic dyslipidemic swine (DD; N = 8 pigs and 304 cells) over the control (C; N = 6 pigs and 264 cells), diabetic (D; N = 5 pigs and 226 cells), and hyperlipidemic (H; N = 5 pigs and 253 cells) swine. Exercise training concurrent with diabetic dyslipidemic (DDX; N = 8 pigs and 315 cells) significantly lowered (#P < 0.05) the basal Ca2+i levels below all groups.

 
Exercise Prevents the Diabetic Dyslipidemia-Induced Impairment in Plasmalemmal Ca2+ Extrusion

Fura 2 imaging was used to assess the contribution of plasmalemmal Ca2+ efflux via both the NCX and the PMCA to the alterations in basal Ca2+i levels. Figure 2A depicts the response of a cell from a control pig to the experimental protocol. Total plasmalemmal Ca2+ efflux was assessed by examining the time to restore Ca2+i levels to half of the peak caffeine response in Ca2+-free solution. In Fig. 2B, the symbols and error bars demonstrate (from left to right) the initial rise, the half-maximum, the peak, the half-recovery and the full recovery of the caffeine response. (In Fig. 2B, the lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group.) In cells from diabetic dyslipidemic swine, the time to half-recovery following the caffeine exposure was significantly prolonged compared with control, suggesting an impaired capacity to remove Ca2+ from the cell (Fig. 2, B and C). Exercise training restored the diabetic dyslipidemia-induced impairment in plasmalemmal Ca2+ efflux to control. Hyperglycemia and hyperlipidemia independently had no significant effect on the recovery time following the caffeine exposure.


Figure 2
View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Exercise training prevented the diabetic dyslipidemia-induced impairment in total plasmalemmal Ca2+ efflux. A: protocol to assess total plasmalemmal Ca2+ efflux. The tracing depicts the response of a control cell to the experimental protocol. The solid horizontal lines below the tracings indicate the solution and exposure duration. Ca2+ free = ~100 nM Ca2+ solution; 80 mM K+ = 80 mM K+ solution; CAF = 5 mM caffeine. B: group averages for landmark points of the caffeine response. For all groups depicted, the average group response ± SE for the initial rise, half-maximum, peak, half-recovery, and full recovery for the caffeine response are shown as symbols with error bars. The lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group. For simplicity, only average responses are shown for the control, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained groups. C: caffeine time to half recovery. Data represent the time (in seconds) to reach the half-recovery level following sarcoplasmic reticulum Ca2+ store depletion with 5 mM caffeine. The recovery time was significantly prolonged (*P < 0.05) in cells from the diabetic dyslipidemic swine (DD; N = 8 pigs and 103 cells) above the control (C; N = 6 pigs and cells 120 cells); and exercise training (DDX; N = 8 pigs and 102 cells) significantly decreased (#P < 0.05) the diabetic dyslipidemic response time to control. Hyperglycemia (D; N = 5 pigs and 69 cells) and hyperlipidemia (N = 5 pigs and 81 cells) had no significant effect on the caffeine half recovery time.

 
Exercise Training Prevents the Diabetic Dyslipidemia-Induced Decrease in Ca2+ Extrusion Via the Plasmalemmal Ca2+-ATPase

Experimental protocols were designed to more specifically examine the relative contribution of Ca2+ extrusion via the PMCA to the altered regulation of basal Ca2+i levels seen in coronary smooth muscle from diabetic dyslipidemic and exercise-trained diabetic dyslipidemic swine (Fig. 3, A and B). In Fig. 3, C and D, the symbols and error bars demonstrate (from left to right) the initial rise, the half-maximum, the peak, the start of the recovery, the half-recovery, and the full recovery of the 19 mM Na+ responses. (In Fig. 3, C and D, the lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group.) Figure 3E shows that NCX inhibition alone is not sufficient to increase basal Ca2+i in diabetic dyslipidemia. This indicates that the NCX alone does not regulate basal Ca2+i and that either the SERCA and/or the PMCA can compensate for NCX inhibition. In the exercise-trained group, the decreased change in the fura 2 response when only the NCX is inhibited (Fig. 3E), together with the exercise-induced improvement of total Ca2+ extrusion, is consistent with increased Ca2+ extrusion via the PMCA in exercise-trained pigs. On inhibition of the SERCA and the NCX, Ca2+i buffering was slightly impaired in cells from diabetic and hyperlipidemic swine and significantly impaired in cells from diabetic dyslipidemic swine (Fig. 3F). These results implicate deficits in the PMCA as at least one early factor in the dysregulation of Ca2+i levels in proatherogenic states. Exercise training concurrent with diabetic dyslipidemia prevented the diabetic dyslipidemia-induced impairment in plasmalemmal Ca2+ efflux via the PMCA, suggesting that exercise training enhanced Ca2+ transport by the PMCA. Diabetes and hyperlipidemia independently had no significant effect on the change in the Ca2+i levels in response to the 19 mM Na+ solution.


Figure 3
View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3. Exercise training prevented the diabetic dyslipidemia-induced impairment in Ca2+i buffering after both the NCX and SERCA are inhibited. A and B: protocols to assess Ca2+ efflux via the Na+-Ca2+ exchanger (NCX) and the plasma membrane Ca2+-ATPase (PMCA). Tracings depict the response of control cells to the experimental protocols. A: protocol without thapsigargin treatment. B: protocol with thapsigargin included in the caffeine solution. 19 mM Na+ = 19 mM Na+ solution; CAF = 5 mM caffeine; TG = 10 µM thapsigargin. C and D: group averages for landmark points of the 19 mM Na+ responses. For all groups depicted, the average group response ± SE for the initial rise, half-maximum, peak, start of recovery, half-recovery, and full recovery for the 19 mM Na+ response are shown as symbols with error bars. The lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group. For simplicity, only traces from the control, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained groups are shown. E: NCX inhibition only. Data represent the change in the Ca2+i response (fura 2 signal) to 19 mM Na+ in the absence of thapsigargin. The change in the fura 2 response was significantly reduced (@P < 0.05) in cells from the exercise-trained, diabetic dyslipidemic swine (DDX; N = 7 pigs and 87 cells) below control (C; N = 5 pigs and 70 cells), diabetic (D; N = 5 pigs and 68 cells), hyperlipidemic (H; N = 4 pigs and 79 cells), and diabetic dyslipidemia (DD; N = 7 pigs and 125 cells) groups. F: NCX and SERCA inhibition. Data represent the change in the Ca2+i response to 19 mM Na+ in the presence of the irreversible SERCA inhibitor thapsigargin. The change in the fura 2 response was significantly increased (*P < 0.05) in cells from the DD (N = 7 pigs and 125 cells) over the C (N = 5 pigs and 72 cells). Exercise training (DDX; N = 7 pigs and 118 cells) significantly decreased (#P < 0.05) the response below that from the diabetic dyslipidemic state. The response was slightly, but not significantly, increased in cells from D (N = 4 pigs and 76 cells) and H (N = 5 pigs and 88 cells) swine.

 
Exercise Prevents the Diabetic Dyslipidemia-Induced Increase in Sarcoplasmic Reticulum Ca2+i Buffering and SERCA2b Protein Expression

A previous study has shown that sarcoplasmic reticulum Ca2+ buffering is increased by diabetic dyslipidemia (23). To assess sarcoplasmic reticulum Ca2+ buffering capacity in this study, we utilized fura 2 imaging and a protocol that has previously been shown in our laboratory to assess sarcoplasmic reticulum Ca2+ uptake (23) (Fig. 4A), assuming known Ca2+ influx. In Fig. 4B, the symbols and error bars demonstrate (from left to right) the initial rise, the half-maximum, the peak, and the start of the recovery for the 80 mM K+ responses. (In Fig. 4B, the lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group.) As shown in Fig. 4C, in cells from diabetic dyslipidemic swine, the time to reach the half-maximal level in response to the second 80 mM K+ solution was significantly increased compared with control. This result, using a protocol different from our laboratory's previous studies, was consistent with those earlier findings demonstrating an increase in sarcoplasmic reticulum Ca2+ buffering capacity with diabetic dyslipidemia (23). Since enhanced SERCA activity would be expected to lower basal Ca2+i levels, although in diabetic dyslipidemia basal Ca2+i is increased, this finding is consistent with the hypothesis that SERCA activity is increased to compensate, albeit inadequately, for decreased Ca2+ extrusion and/or increased Ca2+ influx. Exercise training completely prevented the diabetic dyslipidemia-induced increase in sarcoplasmic reticulum Ca2+ buffering. The time to reach the half-maximal response was slightly increased in the diabetic and hyperlipidemic groups compared with control, but this was not significant.


Figure 4
View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4. Exercise training prevented the diabetic dyslipidemia-induced increase in sarcoplasmic reticulum Ca2+ buffering. A: protocol to assess total plasmalemmal Ca2+ efflux. The tracing depicts the response of a control cell to the experimental protocol. The solid horizontal lines below the tracings indicate the solution and exposure duration. Ca2+-free = ~100 nM Ca2+ solution; 80 mM K+ = 80 mM K+ solution; CAF = 5 mM caffeine. B: group averages for landmark points of the 80 mM K+ responses. For all groups depicted, the average group response ± SE for the initial rise, half-maximum, peak, and start of the recovery for the 80 mM K+ responses are shown as symbols with error bars. Lines are only provided to demonstrate the general shape of the response and do not represent the average response of all of the cells in that treatment group. For simplicity, only average responses are shown for the control, diabetic dyslipidemic, and diabetic dyslipidemic plus exercise-trained groups. C: 80 mM K+ time to half-maximum. Data represent the time (in seconds) to reach the half-maximal response to 80 mM K+-induced Ca2+ influx. For the first 80 mM K+ exposure (80K1), there was no significant difference in the time to reach the half-maximal response. The time to reach the half-maximal response for the second 80 mM K+ exposure (80K2) was significantly prolonged (*P < 0.05) in cells from the DD (N = 8 pigs and 79 cells) above the C (N = 6 pigs and 109 cells), but not the D (N = 5 pigs and 54 cells) or H swine (N = 5 pigs and 71 cells). Exercise training (DDX; N = 7 pigs and 96 cells) prevented (#P < 0.05) the increase in the diabetic dyslipidemic response time.

 
In addition to the assessment of sarcoplasmic reticulum Ca2+ buffering, immunoblot analysis was performed to assess SERCA2b protein expression. Previous findings in porcine coronary smooth muscle had demonstrated an increase in the protein expression of SERCA2b with diabetic dyslipidemia (23). The present study demonstrates that the rise in the protein expression of SERCA2b in diabetic dyslipidemia was prevented by exercise training (Fig. 5). There was no significant change in the protein expression of SERCA2b in the diabetic or hyperlipidemic groups.


Figure 5
View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5. Exercise prevented the diabetic dyslipidemia-induced increase in SERCA2b protein expression. Each band represents 20 µg of sample protein. Data represent the ratio of the band densities for the diabetic (D; N = 5 pigs), hyperlipidemic (H; N = 4 pigs), diabetic dyslipidemic (DD; N = 6 pigs), and diabetic dyslipidemic plus exercise-trained (DDX; N = 7 pigs) swine to control (C; N = 6 pigs). *P < 0.05 vs. all groups.

 
L-Type Voltage-Gated Ca2+ Channel Current Density Was Decreased by Diabetic Dyslipidemia and Exercise Prevented This Decrease

To determine whether exercise training prevented diabetic dyslipidemia-induced alterations in Ca2+ influx via L-type voltage-gated Ca2+ channels, whole cell patch-clamp analysis was performed on freshly isolated cells. Figure 6, top, shows representative 10 mM Ba2+ current traces from coronary smooth muscle cells elicited by test pulse to +10 mV from the holding potential of –80 mV. The magnitude of both the peak and sustained inward current was decreased in cells from the diabetic, hyperlipidemic, and diabetic dyslipidemic groups compared with control. Thus hyperglycemia and hyperlipidemia independently decrease whole cell Ca2+ channel currents, and these decreases were not additive, as evidenced by the similar decrease in peak current in the diabetic dyslipidemic group compared with control. In contrast, the magnitude of both the peak and sustained inward current was returned to control levels in diabetic dyslipidemic animals that were endurance exercise trained for 16–18 wk.


Figure 6
View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6. Exercise prevented the decrease in voltage-gated Ca2+ channel currents elicited by diabetic dyslipidemia. Top: representative Ca2+ current traces. Bottom: representative current-voltage relationships. For clarity, only the peak inward current for the diabetic and hyperlipidemic groups at +20 mV were plotted and not the entire current-voltage relationship. Mean current densities at –20 mV were decreased ~50% in cells from diabetic (N = 5 pigs and 24 cells), hyperlipidemic (N = 4 pigs and 15 cells), and diabetic dyslipidemic swine (N = 6 pigs and 26 cells) from control (N = 6 pigs and 35 cells). Exercise training prevented the diabetic dyslipidemia-induced decrease in voltage-gated current density (N = 6 pigs and 26 cells) and restored currents to control levels. *Statistically significant difference (P < 0.05).

 
The effects of diabetes, hyperlipidemia, diabetic dyslipidemia, and the combined effects of diabetic dyslipidemia plus exercise training on the current vs. voltage (I–V) relationships for coronary smooth muscle cells using 10 mM Ba2+ as the charge carrier are shown in Fig. 6, bottom. Hyperglycemia, hyperlipidemia, and diabetic dyslipidemia significantly decreased peak voltage-gated Ca2+ channel current density by 50% compared with control, whereas exercise-trained diabetic dyslipidemic swine maintained peak voltage-gated Ca2+ channel current density at control levels. In control and exercise-trained diabetic dyslipidemic swine, inward current was significantly different from diabetic, hyperlipidemic, and diabetic dyslipdemic at –10-, 0-, +10-, +20-, and +30-mV test potentials (Fig. 6, bottom). There was no difference in steady-state inactivation of the currents nor in cell capacitance (data not shown).


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The main findings from this study are in support of the overall hypothesis that aerobic exercise training prevents the diabetic dyslipidemia-induced impairment of coronary smooth muscle Ca2+i regulation. Using freshly isolated porcine coronary smooth muscle cells, we demonstrated that exercise training prevents diabetic dyslipidemia-induced decreased plasmalemmal Ca2+ efflux via the PMCA, increased basal Ca2+i levels, increased SERCA activity and protein expression, and decreased voltage-gated Ca2+ channel current density (i.e., Ca2+ influx).

In this study, alloxan treatment elicited approximately sixfold increases in fasting blood glucose levels in all diabetic groups (i.e., the diabetic, diabetic dyslipidemic, and exercise-trained diabetic dyslipidemic groups), and these levels were tightly maintained even in the exercise group. Thus, even though exercise is widely known to increase skeletal muscle insulin sensitivity, which would act to lower blood glucose levels, close monitoring of food intake and exogenous insulin supplementation allowed for us to conclude that exercise training has effects on the vasculature that are independent of glycemic status in this study (5).

Consistent with previous findings from our laboratory (45), in this study, we observed a diabetic dyslipidemia-induced impairment in total plasmalemmal Ca2+ efflux that was restored to control levels by exercise training (Fig. 2, B and C). Although we cannot yet completely dismiss the possible contribution of Ca2+i buffering via mitochondria and/or Ca2+i binding proteins (e.g., calmodulin), these data, taken collectively with other findings from this paper, strongly suggest that exercise training prevents the diabetic dyslipidemia-induced impairment in Ca2+ regulation via enhanced PMCA activity or protein expression. Immunoblot analyses to assess the protein expression of the NCX and/or the PMCA are currently hindered by the lack of commercially available antibodies that are reactive with these proteins in porcine coronary smooth muscle.

Exercise training not only completely reversed the diabetic dyslipidemia-induced rise in basal Ca2+i levels but significantly lowered it compared with control, suggesting a significant beneficial effect of exercise training on impaired Ca2+i regulation associated with diabetes (21, 23, 28, 44). This finding is in contrast with a previous study in our laboratory demonstrating no effect of exercise on the diabetic dyslipidemia-induced rise in basal coronary smooth muscle Ca2+i levels (45). One possible explanation for the differences is that the swine in the present study were not allowed to gain as much weight as the swine in the previous study. In the previous study, the diabetic dyslipidemic and exercise-trained diabetic dyslipidemic swine increased their body weights by ~60% over the 20-wk treatment period (45), whereas in the current study the weight gain was limited to ~20%. It seems reasonable that this large difference in body weight hindered the ability of the swine in the previous study to fully benefit from the effects of the exercise training bouts.

In diabetic dyslipidemia, enhanced Ca2+i buffering by SERCA has been consistently observed in smooth muscle studies performed in our laboratory and others (17, 21, 23). The findings from this study (Fig. 5) were in agreement with the previous studies. Since the diabetic dyslipidemic condition is associated with impaired plasmalemmal Ca2+ efflux and elevated basal Ca2+i levels, the increase in sarcoplasmic reticulum Ca2+ buffering is interpreted as a compensatory alteration. The enhanced SERCA activity seen in diabetic dyslipidemia was concurrently observed with an increased expression of the SERCA2b protein (Fig. 5) and was consistent with our laboratory's previous study in porcine coronary arteries (23). An extension of this previous work was our finding that exercise training concurrent with diabetic dyslipidemia restored both sarcoplasmic reticulum Ca2+i buffering and SERCA2b protein levels to control (Figs. 4 and 5). Collectively, these data suggest that the effects of exercise were in the prevention of the compensatory increases in SERCA activity and SERCA2b protein expression observed with diabetic dyslipidemia.

Diabetic dyslipidemia-induced alterations in Ca2+ influx via L-type voltage-gated Ca2+ channels did not contribute to the increased basal Ca2+i levels, since whole cell patch-clamp studies demonstrated a significant reduction in peak Ca2+ current in cells from diabetic, hyperlipidemic, and diabetic dyslipidemic swine that was prevented by exercise. This exercise-induced increase in Ca2+ influx above that in diabetic dyslipidemia was consistent with previous studies done in coronary smooth muscle from low-fat-fed, exercise-trained swine that saw a significant increase in peak Ca2+ current with exercise above that in sedentary swine (8). However, this exercise-induced prevention of decreased peak Ca2+ current in diabetic dyslipidemia was in conflict with the significant decrease in basal Ca2+i levels seen in exercise-trained diabetic dyslipidemic pigs (Fig. 6) and suggests that, like the increase in SERCA activity and protein expression, the decrease in peak Ca2+ current may be a compensatory change. Moreover, it is interesting to speculate that the decrease in L-type voltage-gated Ca2+ channel current density may play a role in regulating coronary smooth muscle cell phenotype in the diabetic dyslipidemia-induced diseased state. A recent study by Wamhoff et al. (42) showed that L-type voltage-gated Ca2+ channels were required for the maintenance of the contractile phenotype and that positive regulation of smooth muscle cell differentiation marker genes. Although not described herein, we have shown that, in the same diabetic dyslipidemic swine utilized in this study, diabetic dyslipidemia increased coronary atheroma development (30), a potential yet undefined mechanism linking Ca2+i dysregulation to smooth muscle cell phenotypic modulation in atherosclerosis.

In summary, the main findings from this study demonstrate that exercise training is able to prevent diabetic dyslipidemia-induced alterations in coronary smooth muscle Ca2+i regulation. This includes a restoration of the diabetic dyslipidemia-induced decrease in plasmalemmal Ca2+ efflux via the PMCA, increase in SERCA activity and protein expression, and decrease in Ca2+ influx via L-type voltage-gated Ca2+ channels to control levels. In addition, exercise training significantly lowered basal Ca2+i levels and enhanced non-NCX-induced Ca2+i buffering compared with control cells, suggesting that exercise training is doing more than just preventing the diabetic dyslipidemia-induced alterations in Ca2+i handling.

In view of these findings, we propose a model for the diabetic dyslipidemia-induced impairment of coronary smooth muscle Ca2+i regulation and the mechanism by which exercise prevents the detrimental alterations. We speculate that the initial defect in Ca2+i regulation is an impairment in plasmalemmal Ca2+ efflux that then results in an increase in whole cell Ca2+i levels. In response to this rise, the cell activates a compensatory response that includes increasing Ca2+ uptake into the sarcoplasmic reticulum and decreasing Ca2+ entry into the cell. However, as evidenced by the increased basal Ca2+i levels observed in the cells from the diabetic dyslipidemic swine, the compensatory responses do not completely prevent the rise in basal Ca2+i levels. Exercise training concurrent with the diabetic dyslipidemic state restored most of the diabetic dyslipidemia-induced alterations in Ca2+i transporters to control levels, suggesting that exercise training prevents the initial defect in plasmalemmal Ca2+ efflux. Alternatively, since exercise training significantly lowered basal Ca2+i levels below control, and this was observed concurrent with enhanced Ca2+i buffering via non-NCX mechanisms, it suggests that exercise training may be enhancing Ca2+ efflux via the PMCA. Future studies should focus on elucidating which of these possibilities are responsible for the beneficial effects of exercise training on coronary smooth muscle Ca2+i regulation.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by grants from the National Institutes of Health (RR-13223 and HL-62552) to M. Sturek and Fellowships from the American Heart Association to B. R. Wamhoff.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank Dr. Joseph Dixon for plasma lipid assays.


    FOOTNOTES
 

Address for reprint requests and other correspondence: M. Sturek, Dept. of Cellular & Integrative Physiology, Indiana Univ. School of Medicine, 635 Barnhill Dr., MS 385, Indianapolis, IN 46202-5120 (e-mail: msturek{at}iupui.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Bagwell CA and Brophy C. Enhanced arterial contractile responses in diabetic hypercholesterolemic pig carotid arteries. Int J Surg Invest 1: 477–481, 2000.
  2. Bean BP, Sturek M, Puga A, and Hermsmeyer K. Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ Res 59: 229–235, 1986.[Abstract/Free Full Text]
  3. Beaver BV, Reed W, Leary S, McKiernan B, Bain F, Schultz R, Bennett BT, Pascoe P, Shull E, Cork LC, Francis-Floyd R, Amass KD, Johnson R, Schmidt RH, Underwood W, Thornton GW, and Kohn B. 2000 Report of the AVMA Panel on Euthanasia. JAMA 218: 669–696, 2001.
  4. Berlin JA and Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 132: 612–628, 1990.[Abstract/Free Full Text]
  5. Boullion RD, Mokelke EA, Wamhoff BR, Otis CR, Wenzel J, Dixon JL, and Sturek M. Porcine model of diabetic dyslipidemia: insulin and feed algorithms for mimicking diabetes in humans. Comp Med 53: 42–52, 2003.[ISI][Medline]
  6. Bowles DK, Heaps CL, Turk JR, Maddali KK, and Price EM. Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation. J Appl Physiol 96: 2240–2248, 2004.[Abstract/Free Full Text]
  7. Bowles DK, Hu Q, Laughlin MH, and Sturek M. Heterogeneity of L-type calcium current density in coronary smooth muscle. Am J Physiol Heart Circ Physiol 273: H2083–H2089, 1997.[Abstract/Free Full Text]
  8. Bowles DK, Hu Q, Laughlin MH, and Sturek M. Exercise training increases L-type calcium current density in coronary smooth muscle. Am J Physiol Heart Circ Physiol 275: H2159–H2169, 1998.[Abstract/Free Full Text]
  9. Bowles DK, Laughlin MH, and Sturek M. Exercise training alters the Ca2+ and contractile responses of coronary arteries to endothelin. J Appl Physiol 78: 1079–1087, 1995.[Abstract/Free Full Text]
  10. Bowles DK, Laughlin MH, and Sturek M. Exercise training increases K+ channel contribution to regulation of coronary arterial tone. J Appl Physiol 84: 1225–1233, 1998.[Abstract/Free Full Text]
  11. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Cerai SP, Pagano G, and Cavallo-Perin P. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in Type 2 diabetes. Diabetes Care 27: 2689–2694, 2004.[Abstract/Free Full Text]
  12. Chen Q, Cannell M, and Van Breemen C. The superficial buffer barrier in vascular smooth muscle. Can J Physiol Pharmacol 70: 509–514, 1992.[ISI][Medline]
  13. Chen Q and Van Breemen C. The superficial buffer barrier in venous smooth muscle: sarcoplasmic reticulum refilling and unloading. Br J Pharmacol 109: 336–343, 1993.[ISI][Medline]
  14. Committee to Develop an APS Resource Book for the Design of Animal Exercise Protocols. Exercise protocols using large animals: treadmill exercise in pigs. In: Resource Book for the Design of Animal Exercise Protocols, edited by Kregel KC, Toth LA, Henriksen EJ, and Ra'anan AW. Bethesda, MD: Am. Physiol. Soc., 2006, p. 65–70.
  15. DiCarlo SE, Blair RW, Bishop VS, and Stone HL. Daily exercise enhances coronary resistance vessel sensitivity to pharmacological activation. J Appl Physiol 66: 421–428, 1989.[Abstract/Free Full Text]
  16. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, and Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19: 2981–2992, 1999.[Abstract/Free Full Text]
  17. Fleischhacker E, Esenabhalu VE, Spitaler M, Holzmann S, Skrabal F, Koidl B, Kostner GM, and Graier WF. Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes 48: 1323–1330, 1999.[Abstract]
  18. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB, Wilson PWF, and Savage PJ. Trends in cardiovascular complications of diabetes. JAMA 292: 2495–2499, 2004.[Abstract/Free Full Text]
  19. Heaps CL, Bowles DK, Sturek M, Laughlin MH, and Parker JL. Enhanced L-type Ca2+ channel current density in coronary smooth muscle of exercise-trained swine is compensated to limit myoplasmic free Ca2+ accumulation. J Physiol 528: 435–445, 2000.[Abstract/Free Full Text]
  20. Helmrich SP, Ragland DR, Leung RW, and Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325: 147–152, 1991.[Abstract]
  21. Hill BJF, Dixon JL, and Sturek M. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159: 117–124, 2001.[CrossRef][ISI][Medline]
  22. Hill BJF, Katwa LC, Wamhoff BR, and Sturek M. Enhanced endothelinA receptor-mediated calcium mobilization and contraction in organ cultured porcine coronary arteries. J Pharmacol Exp Ther 295: 484–491, 2000.[Abstract/Free Full Text]
  23. Hill BJF, Price EM, Dixon JL, and Sturek M. Increased calcium buffering in coronary smooth muscle cells from diabetic dyslipidemic pigs. Atherosclerosis 167: 15–23, 2003.[CrossRef][ISI][Medline]
  24. Janssen LJ, Betti PA, Netherton SJ, and Walters DK. Superficial buffer barrier and preferentially directed release of Ca2+ in canine airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 276: L744–L753, 1999.[Abstract/Free Full Text]
  25. Kannel WB and McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 241: 2035–2038, 1979.[Abstract]
  26. Laughlin MH. Effects of exercise training on coronary transport capacity. J Appl Physiol 58: 468–476, 1985.[Abstract/Free Full Text]
  27. Laughlin MH, Overholser KA, and Bhatte MJ. Exercise training increases coronary transport reserve in miniature swine. J Appl Physiol 67: 1140–1149, 1989.[Abstract/Free Full Text]
  28. Lee DL, Wamhoff BR, Katwa LC, Reddy HK, Voelker DJ, Dixon JL, and Sturek M. Increased endothelin-induced Ca2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic swine are prevented by atorvastatin. J Pharmacol Exp Ther 306: 132–140, 2003.[Abstract/Free Full Text]
  29. Mokelke EA, Dietz NJ, Eckman DM, Nelson MT, and Sturek M. Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current. Am J Physiol Heart Circ Physiol 288: H1233–H1241, 2005.[Abstract/Free Full Text]
  30. Mokelke EA, Hu Q, Song M, Toro L, Reddy HK, and Sturek M. Altered functional coupling of coronary K+ channels in diabetic dyslipidemic pigs is prevented by exercise. J Appl Physiol 95: 1179–1193, 2003.[Abstract/Free Full Text]
  31. Natarajan R, Gerrity RG, Gu JL, Lanting L, Thomas L, and Nadler JL. Role of 12-lipoxygenase and oxidant stress in hyperglycemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45: 125–133, 2002.[CrossRef][ISI][Medline]
  32. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
  33. Oltman CL, Parker JL, Adams HR, and Laughlin MH. Effects of exercise training on vasomotor reactivity of porcine coronary arteries. Am J Physiol Heart Circ Physiol 263: H372–H382, 1992.[Abstract/Free Full Text]
  34. Phillips RW and Panepinto LM. Swine as a model for human diabetes. In: Swine in Biomedical Research, edited by Tumbleson ME. New York: Plenum, 1986, p. 549–560.
  35. Rana JS, Monraats PS, Zwinderman AH, De Maat MPM, Kastelein JJP, Doevendans PAF, De Winter RJ, Tio RA, Frants RR, van der Laarse A, Van der Wall EE, and Jukema JW. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 28: 873–877, 2005.[Abstract/Free Full Text]
  36. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485–517, 1970.[Free Full Text]
  37. Stehno-Bittel L, Laughlin MH, and Sturek M. Exercise training alters Ca release from coronary smooth muscle sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 259: H643–H647, 1990.[Abstract/Free Full Text]
  38. Stehno-Bittel L, Laughlin MH, and Sturek M. Exercise training depletes sarcoplasmic reticulum calcium in coronary smooth muscle. J Appl Physiol 71: 1764–1773, 1991.[Abstract/Free Full Text]
  39. Sturek M and Hermsmeyer K. Calcium and sodium channels in spontaneously contracting vascular muscle cells. Science 233: 475–478, 1986.[Abstract/Free Full Text]
  40. Sturek M, Kunda K, and Hu Q. Sarcoplasmic reticulum buffering of myoplasmic calcium in bovine coronary artery smooth muscle. J Physiol 451: 25–48, 1992.[Abstract/Free Full Text]
  41. Wagner-Mann C, Hu Q, and Sturek M. Multiple effects of ryanodine on intracellular free Ca2+ in smooth muscle cells from bovine and porcine coronary artery: modulation of sarcoplasmic reticulum function. Br J Pharmacol 105: 903–911, 1992.[ISI][Medline]
  42. Wamhoff BR, Bowles DK, McDonald OG, Sinha S, Somlyo AP, Somlyo AV, and Owens GK. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res 95: 406–414, 2004.[Abstract/Free Full Text]
  43. Wamhoff BR, Dixon JL, and Sturek M. Exercise training prevents altered coronary smooth muscle L-type calcium channel function in diabetic dyslipidemia (Abstract). Circulation 104: 157, 2001.[Abstract/Free Full Text]
  44. Wamhoff BR, Dixon JL, and Sturek M. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling associated with diabetic dyslipidemia. J Vasc Res 39: 208–220, 2002.[CrossRef][ISI][Medline]
  45. Witczak CA and Sturek M. Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 96: 1069–1079, 2004.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Yang, A. W. Jones, T. R. Thomas, and L. J. Rubin
Influence of sex, high-fat diet, and exercise training on potassium currents of swine coronary smooth muscle
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1553 - H1563.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
101/3/752    most recent
00235.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow